Catégorie
Irinotecan
Numéro CAS
136572-09-3
Autre numéro CAS
Free Base - 97682-44-5 , HCL - 100286-90-6
Formule moléculaire
C33H45ClN4O9
Masse moléculaire
677.18 g/mol
Synonyme

 (S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3`,4`:6,7]indolizino[1,2-b]quinolin-9-yl [1,4`-bipiperidine]-1`-carboxylate hydrochloride trihydrate ; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-;

slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Irinotecan hydrochloride trihydrate is a chemotherapy drug used to treat colorectal and other solid tumors by inhibiting topoisomerase I, which prevents DNA replication in cancer cells and induces cell death. It is typically administered intravenously, often as part of combination chemotherapy regimens, to enhance treatment efficacy and improve patient outcomes.